Success Stories: A Senior Scientist from China Secured EB-2 NIW Petition Approval in Just 5 Days with North America Immigration Law Group’s Support

Case Summary:

Armed with a Ph.D. in chemical engineering, our client, a distinguished senior scientist, demonstrated exceptional expertise in advancing research within the field of protein science and biopharmaceuticals. Seeking our assistance in navigating the I-140 NIW (National Interest Waiver) petition process, we delved into evaluating her qualifications. Drawing insights from her research achievements and professional triumphs, we were convinced that her proposed research endeavors held immense value in the United States. Our primary objective was to showcase to the USCIS the profound benefits her work could bring to the United States, thereby substantiating the need for her to secure the national interest waiver. To bolster our case, we strategically emphasized several pivotal points:

• We indicated our client’s publications which have been cited 20 times from the 5 peer-reviewed journal articles (4 of them first-authored), showing that her publications are noble and most-cited in the field of protein science and biopharmaceuticals.
• We detailed her research on developing biomanufacturing processes to produce therapeutic moieties like biologics, small molecules, and cell and gene therapies to achieve optimal-quality treatments for diseases such as cancer, inflammation, and rare diseases, which is of great importance because it focuses on improving the quality of treatments worldwide for diseases, such as cancer.
• Also, we noted how her work has also been supported by several federally-funded institutions such as the National Institute of Innovation in Manufacturing Biopharmaceuticals and the Defense Threat Reduction Agency. As a result, this study advances her greater objective of improving biomanufacturing processes to generate therapeutic moieties to obtain the highest-quality disease therapies possible.
• Besides, given that the high cost of cancer medications and a scarcity of experts continue to be important factors in cancer’s effect in LIMCs, incorporating our client’s biomanufacturing innovations expands the availability of top-tier therapies. Accordingly, with numerous advantages to improved biomanufacturing, her ongoing research plays a vital role in improving the quality and access to disease treatment globally.
• Lastly, we suggested to our client to arrange a few letters of support to bolster her case. Accordingly, we got four recommendation letters acquired from her from fellow researchers, one of whom contributed the following statement:

“Her field experiences and educational background in chemical engineering have honed her skills in experimentation, including the use of biochemical assays and cell culture, as well as her computational proficiencies in areas like machine learning, modeling, and simulation. Based on the rigor of her knowledge and skill set, it is clear that [our client] is an asset to the American scientific community.”

With her exceptional expertise in therapeutic protein production and process development, groundbreaking research, and significant contributions to advancing biomanufacturing processes, it is crystal clear that she is leading the way in her field. Our successful communication with the USCIS highlighted the tremendous value of her work, which focuses on the cost-effective production of vital therapeutic products, including biologics for treating diseases like cancer.

Therefore, USCIS swiftly approved her NIW case in just 5 days, a testament to our unwavering support and dedication. We express our heartfelt gratitude to her for entrusting us with this process and allowing us to play a role in this remarkable achievement. Congratulations to her on reaching this important milestone.